✦ LIBER ✦

Combination chemotherapy for unresectable lung cancer — Prevention of delay of courses and chemotherapy-induced neutropenia with administration of rhG-CSF

Book ID: 122629651
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 131 KB
Volume: 13
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(95)90649-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of OK-432 in combination with rhG

Effect of OK-432 in combination with rhG-CSF on thrombocytopenia during chemotherapy for lung cancer

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Effect of recombinant human G-CSF (rhG-C

Effect of recombinant human G-CSF (rhG-CSF) in patients with non-small, cell lung cancer (NSCLC) treated with combination chemotherapy of cisplatin, ifosfamide, and indesine (CIV chemotherapy)

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Effectiveness of palonosetron for preven

Effectiveness of palonosetron for preventing delayed chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy in patients with gastrointestinal cancer

✍ Murakami, Michiyasu; Hashimoto, Hiroki; Yamaguchi, Kyohei; Yamaguchi, Ikuko; Sen 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 180 KB

9048 Aprepitant for the prevention of ch

9048 Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic (MEC) or highly emetogenic (HEC) chemotherapies in patients with lung cancer

✍ Rapoport, B.; Boice, J.A.; Brown, C.; Street, J.C.; Hardwick, J.S.; Carides, A.D 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB

P-688 Patterns of care and risk of chemo

P-688 Patterns of care and risk of chemotherapy-induced neutropenia and anemia in patients with lung cancer: Preliminary results from a prospective registry for risk model development

✍ Crawford, Jeffrey; Dale, David; Wolff, Debra A.; Agboola, Olayemi; Lyman, Gary H 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 377 KB

Phase 2 trial results with the novel neu

Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy

✍ Wichit Arpornwirat; Istvan Albert; Vincent L. Hansen; Jeremey Levin; Rajesh R. B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views